pharma · high blood pressure · increased blood clotting
APREMEDA s.r.o
s.r.o.
APREMEDA s.r.o clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
EU HQ
2020 Founded
18 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Founded
- 2020
- Employees
- 18
- Programs
- 5
- Drugs
- 16
- Patents
- 0
APREMEDA s.r.o projects
0 ClinicalTrials.gov programs sponsored by APREMEDA s.r.o.
APREMEDA s.r.o has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does APREMEDA s.r.o have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.